Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions David Burrows
PDL BioPharmaPDLIDON'T BUYJul 12, 2006
Higher valuation stocks are going to have a tougher time when people are concerned about a slowing economy. This one has been weakening since March. There is no sign of any real bounce on the little bit of recent strength.
$17.80
Stock price when the opinion was issued
$2.56
As of Dec 30, 2020. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Company is developing compounds which won't harm the body but will help. Multi-billion dollar business. He has owned it for about 3
months and continues to buy.
David BurrowsOwned
biotechnologypharmaceutical
